Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

32 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
COVID-19 Incidence and Mortality Among Unvaccinated and Vaccinated Persons Aged ≥12 Years by Receipt of Bivalent Booster Doses and Time Since Vaccination - 24 U.S. Jurisdictions, October 3, 2021-December 24, 2022.
Johnson AG, Linde L, Ali AR, DeSantis A, Shi M, Adam C, Armstrong B, Armstrong B, Asbell M, Auche S, Bayoumi NS, Bingay B, Chasse M, Christofferson S, Cima M, Cueto K, Cunningham S, Delgadillo J, Dorabawila V, Drenzek C, Dupervil B, Durant T, Fleischauer A, Hamilton R, Harrington P, Hicks L, Hodis JD, Hoefer D, Horrocks S, Hoskins M, Husain S, Ingram LA, Jara A, Jones A, Kanishka FNU, Kaur R, Khan SI, Kirkendall S, Lauro P, Lyons S, Mansfield J, Markelz A, Masarik J 3rd, McCormick D, Mendoza E, Morris KJ, Omoike E, Patel K, Pike MA, Pilishvili T, Praetorius K, Reed IG, Severson RL, Sigalo N, Stanislawski E, Stich S, Tilakaratne BP, Turner KA, Wiedeman C, Zaldivar A, Silk BJ, Scobie HM. Johnson AG, et al. Among authors: wiedeman c. MMWR Morb Mortal Wkly Rep. 2023 Feb 10;72(6):145-152. doi: 10.15585/mmwr.mm7206a3. MMWR Morb Mortal Wkly Rep. 2023. PMID: 36757865 Free PMC article.
Serial Interval and Incubation Period Estimates of Monkeypox Virus Infection in 12 Jurisdictions, United States, May-August 2022.
Madewell ZJ, Charniga K, Masters NB, Asher J, Fahrenwald L, Still W, Chen J, Kipperman N, Bui D, Shea M, Saunders K, Saathoff-Huber L, Johnson S, Harbi K, Berns AL, Perez T, Gateley E, Spicknall IH, Nakazawa Y, Gift TL; 2022 Mpox Outbreak Response Team. Madewell ZJ, et al. Emerg Infect Dis. 2023 Apr;29(4):818-821. doi: 10.3201/eid2904.221622. Epub 2023 Mar 2. Emerg Infect Dis. 2023. PMID: 36863012 Free PMC article.
Demographic and Clinical Characteristics of Mpox in Persons Who Had Previously Received 1 Dose of JYNNEOS Vaccine and in Unvaccinated Persons - 29 U.S. Jurisdictions, May 22-September 3, 2022.
Farrar JL, Lewis NM, Houck K, Canning M, Fothergill A, Payne AB, Cohen AL, Vance J, Brassil B, Youngkin E, Glenn B, Mangla A, Kupferman N, Saunders K, Meza C, Nims D, Soliva S, Blouse B, Henderson T, Banerjee E, White B, Birn R, Stadelman AM, Abrego M, McLafferty M, Eberhart MG, Pietrowski M, De León SM, Creegan E, Diedhiou A, Wiedeman C, Murray-Thompson J, McCarty E, Marcinkevage J, Kocharian A, Torrone EA, Ray LC, Payne DC; Mpox Cases in Vaccinated Persons Team. Farrar JL, et al. Among authors: wiedeman c. Am J Transplant. 2023 Feb;23(2):298-303. doi: 10.1016/j.ajt.2023.01.003. Epub 2023 Jan 11. Am J Transplant. 2023. PMID: 36695684 Free article. No abstract available.
Demographic and Clinical Characteristics of Mpox in Persons Who Had Previously Received 1 Dose of JYNNEOS Vaccine and in Unvaccinated Persons - 29 U.S. Jurisdictions, May 22-September 3, 2022.
Farrar JL, Lewis NM, Houck K, Canning M, Fothergill A, Payne AB, Cohen AL, Vance J, Brassil B, Youngkin E, Glenn B, Mangla A, Kupferman N, Saunders K, Meza C, Nims D, Soliva S, Blouse B, Henderson T, Banerjee E, White B, Birn R, Stadelman AM, Abrego M, McLafferty M, Eberhart MG, Pietrowski M, De León SM, Creegan E, Diedhiou A, Wiedeman C, Murray-Thompson J, McCarty E, Marcinkevage J, Kocharian A, Torrone EA, Ray LC, Payne DC; Mpox Cases in Vaccinated Persons Team. Farrar JL, et al. Among authors: wiedeman c. MMWR Morb Mortal Wkly Rep. 2022 Dec 30;71(5152):1610-1615. doi: 10.15585/mmwr.mm715152a2. MMWR Morb Mortal Wkly Rep. 2022. PMID: 36580416 Free PMC article.
Covid-19 Rates by Time since Vaccination during Delta Variant Predominance.
Paz-Bailey G, Sternberg M, Kugeler K, Hoots B, Amin AB, Johnson AG, Barbeau B, Bayoumi NS, Bertolino D, Boulton R, Brown CM, Busen K, Cima M, Drenzek C, Gent A, Haney G, Hicks L, Hook S, Jara A, Jones A, Kamal-Ahmed I, Kangas S, Kanishka FNU, Khan SI, Kirkendall SK, Kocharian A, Lyons BC, Lauro P, McCormick D, McMullen C, Milroy L, Reese HE, Sell J, Sierocki A, Smith E, Sosin D, Stanislawski E, Strand K, Troelstrup T, Turner KA, Vest H, Warner S, Wiedeman C, Silk B, Scobie HM. Paz-Bailey G, et al. Among authors: wiedeman c. NEJM Evid. 2022 Jan 10;1(3):10.1056/evidoa2100057. doi: 10.1056/evidoa2100057. NEJM Evid. 2022. PMID: 37207114 Free PMC article.
Notes from the Field: Comparison of COVID-19 Mortality Rates Among Adults Aged ≥65 Years Who Were Unvaccinated and Those Who Received a Bivalent Booster Dose Within the Preceding 6 Months - 20 U.S. Jurisdictions, September 18, 2022-April 1, 2023.
Johnson AG, Linde L, Payne AB, Ali AR, Aden V, Armstrong B, Armstrong B, Auche S, Bayoumi NS, Bennett S, Boulton R, Chang C, Collingwood A, Cueto K, Davidson SL, Du Y, Fleischauer A, Force V, Frank D, Hamilton R, Harame K, Harrington P, Hicks L, Hodis JD, Hoskins M, Jones A, Kanishka F, Kaur R, Kirkendall S, Khan SI, Klioueva A, Link-Gelles R, Lyons S, Mansfield J, Markelz A, Masarik J 3rd, Mendoza E, Morris K, Omoike E, Paritala S, Patel K, Pike M, Pompa XP, Praetorius K, Rammouni N, Razzaghi H, Riggs A, Shi M, Sigalo N, Stanislawski E, Tilakaratne BP, Turner KA, Wiedeman C, Silk BJ, Scobie HM. Johnson AG, et al. Among authors: wiedeman c. MMWR Morb Mortal Wkly Rep. 2023 Jun 16;72(24):667-669. doi: 10.15585/mmwr.mm7224a6. MMWR Morb Mortal Wkly Rep. 2023. PMID: 37319029 Free PMC article. No abstract available.
Application of a life table approach to assess duration of BNT162b2 vaccine-derived immunity by age using COVID-19 case surveillance data during the Omicron variant period.
Sternberg MR, Johnson A, King J, Ali AR, Linde L, Awofeso AO, Baker JS, Bayoumi NS, Broadway S, Busen K, Chang C, Cheng I, Cima M, Collingwood A, Dorabawila V, Drenzek C, Fleischauer A, Gent A, Hartley A, Hicks L, Hoskins M, Jara A, Jones A, Khan SI, Kamal-Ahmed I, Kangas S, Kanishka F, Kleppinger A, Kocharian A, León TM, Link-Gelles R, Lyons BC, Masarik J, May A, McCormick D, Meyer S, Milroy L, Morris KJ, Nelson L, Omoike E, Patel K, Pietrowski M, Pike MA, Pilishvili T, Peterson Pompa X, Powell C, Praetorius K, Rosenberg E, Schiller A, Smith-Coronado ML, Stanislawski E, Strand K, Tilakaratne BP, Vest H, Wiedeman C, Zaldivar A, Silk B, Scobie HM. Sternberg MR, et al. Among authors: wiedeman c. PLoS One. 2023 Sep 20;18(9):e0291678. doi: 10.1371/journal.pone.0291678. eCollection 2023. PLoS One. 2023. PMID: 37729332 Free PMC article.
Estimated Effectiveness of JYNNEOS Vaccine in Preventing Mpox: A Multijurisdictional Case-Control Study - United States, August 19, 2022-March 31, 2023.
Dalton AF, Diallo AO, Chard AN, Moulia DL, Deputy NP, Fothergill A, Kracalik I, Wegner CW, Markus TM, Pathela P, Still WL, Hawkins S, Mangla AT, Ravi N, Licherdell E, Britton A, Lynfield R, Sutton M, Hansen AP, Betancourt GS, Rowlands JV, Chai SJ, Fisher R, Danza P, Farley M, Zipprich J, Prahl G, Wendel KA, Niccolai L, Castilho JL, Payne DC, Cohn AC, Feldstein LR; CDC Multijurisdictional Mpox Case-Control Study Group; CDC Multijurisdictional Mpox Case Control Study Group. Dalton AF, et al. MMWR Morb Mortal Wkly Rep. 2023 May 19;72(20):553-558. doi: 10.15585/mmwr.mm7220a3. MMWR Morb Mortal Wkly Rep. 2023. PMID: 37200229 Free PMC article.
32 results